Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Di Pressa F"'
Publikováno v:
In Orthopaedics & Traumatology: Surgery & Research June 2018 104(4):533-538
Publikováno v:
In Revue de Chirurgie Orthopedique et Traumatologique June 2018 104(4):379-379
Autor:
Maffei, N., Meduri, B., Itta, F., Ashraf, N., Gutierrez, M.V., Bernabei, A., Zanella, E., Di Pressa, F., D'Angelo, E., Mazzeo, E., Lohr, F., Guidi, G.
Publikováno v:
In Radiotherapy and Oncology May 2023 182 Supplement 1:S783-S784
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Federico Iori, Alessio Bruni, Salvatore Cozzi, Patrizia Ciammella, Francesca Di Pressa, Luca Boldrini, Carlo Greco, Valerio Nardone, Viola Salvestrini, Isacco Desideri, Francesca De Felice, Cinzia Iotti
Despite the rising evidence in favor of immunotherapy (IT), the treatment of oncological patients affected by so-called “cold tumors” still represents an open issue. Cold tumors are characterized by an immunosuppressive (so-called cold) tumor mic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36cc77da9bb769a3812414bd71df5068
https://hdl.handle.net/11591/483770
https://hdl.handle.net/11591/483770
Introduction: The humerus is the second most common long bone site of metastatic disease from renal cell carcinomas (RCC) after femur. Surgery has an important role in the treatment of these lesions due to renal cell tumor's resistance to chemotherap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa4980107d77e3e02bd655aa210e2368
http://hdl.handle.net/11585/672798
http://hdl.handle.net/11585/672798
Autor:
De Rose F; Radiation Oncology, APSS, Trento, Italy., Carmen De Santis M; Radiation Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Lucidi S; Radiation Oncology, APSS, Trento, Italy., Ray Colciago R; School of Medicine and Surgery, University of Milan Bicocca, Milan, Italy. Electronic address: riccardoraycolciago@gmail.com., Marino L; Servizio di Radioterapia, Humanitas Istituto Clinico Catanese, Misterbianco, CT, Italy., Cucciarelli F; Radiotherapy Department, Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy., La Rocca E; Department of Radiation Oncology, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy., Di Pressa F; Department of Radiation Oncology, University Hospital of Modena, Modena, Italy., Lohr F; Proton Therapy Unit, APSS, Trento, Italy; CISMED - Centro Interdipartimentale di Scienze Mediche, University of Trento, Trento, Italy., Vanoni V; Radiation Oncology, APSS, Trento, Italy., Meduri B; Department of Radiation Oncology, University Hospital of Modena, Modena, Italy.
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Oct 19; Vol. 202, pp. 110591. Date of Electronic Publication: 2024 Oct 19.
Autor:
Di Pressa F; Radiation Therapy Unit, Department of Oncology and Hematology, University Hospital of Modena, 41124 Modena, Italy., Perrone F; Medical Oncology Unit, University Hospital of Parma, 43126 Parma, Italy., Benini A; Radiation Therapy Unit, Department of Oncology and Hematology, University Hospital of Modena, 41124 Modena, Italy., Lohr F; Proton Therapy Unit, APSS Trento and CISMed, University of Trento, 38100 Trento, Italy., Tiseo M; Medical Oncology Unit, University Hospital of Parma, 43126 Parma, Italy.; Department of Medicine and Surgery, University Hospital of Parma, 43126 Parma, Italy., Bruni A; Radiation Therapy Unit, Department of Oncology and Hematology, University Hospital of Modena, 41124 Modena, Italy.
Publikováno v:
Exploration of targeted anti-tumor therapy [Explor Target Antitumor Ther] 2024; Vol. 5 (3), pp. 449-464. Date of Electronic Publication: 2024 May 17.